AMGEN Q3 2026 REVENUE $10.37 BLN, ABOVE ESTIMATE OF $10.05 BLN, WITH ADJUSTED EPS $6.45, ABOVE ESTIMATE OF $5.77, AND ADJUSTED OPERATING INCOME $4.68 BLN, ABOVE ESTIMATE OF $4.33 BLN 03-NOV-2026 04:04 PM ET